» Articles » PMID: 35721356

Current Steering Using Multiple Independent Current Control Deep Brain Stimulation Technology Results in Distinct Neurophysiological Responses in Parkinson's Disease Patients

Overview
Specialty Neurology
Date 2022 Jun 20
PMID 35721356
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Deep brain stimulation (DBS) is an effective neuromodulation therapy to treat people with medication-refractory Parkinson's disease (PD). However, the neural networks affected by DBS are not yet fully understood. Recent studies show that stimulating on different DBS-contacts using a single current source results in distinct EEG-based evoked potentials (EPs), with a peak at 3 ms (P3) associated with dorsolateral subthalamic nucleus stimulation and a peak at 10 ms associated with substantia nigra stimulation. Multiple independent current control (MICC) technology allows the center of the electric field to be moved in between two adjacent DBS-contacts, offering a potential advantage in spatial precision.

Objective: Determine if MICC precision targeting results in distinct neurophysiological responses recorded EEG.

Materials And Methods: We recorded cortical EPs in five hemispheres (four PD patients) using EEG whilst employing MICC to move the electric field from the most dorsal DBS-contact to the most ventral in 15 incremental steps.

Results: The center of the electric field location had a significant effect on both the P3 and P10 amplitude in all hemispheres where a peak was detected (P3, detected in 4 of 5 hemispheres, < 0.0001; P10, detected in 5 of 5 hemispheres, < 0.0001). analysis indicated furthermore that MICC technology can significantly refine the resolution of steering.

Conclusion: Using MICC to incrementally move the center of the electric field to locations between adjacent DBS-contacts resulted in significantly different neurophysiological responses that may allow further precision of the programming of individual patients.

Citing Articles

EEG-based biomarkers for optimizing deep brain stimulation contact configuration in Parkinson's disease.

Peeters J, Van Bogaert T, Boogers A, Dembek T, Gransier R, Wouters J Front Neurosci. 2023; 17:1275728.

PMID: 37869517 PMC: 10585033. DOI: 10.3389/fnins.2023.1275728.


Towards biomarker-based optimization of deep brain stimulation in Parkinson's disease patients.

Peeters J, Boogers A, Van Bogaert T, Dembek T, Gransier R, Wouters J Front Neurosci. 2023; 16:1091781.

PMID: 36711127 PMC: 9875598. DOI: 10.3389/fnins.2022.1091781.

References
1.
Wagle Shukla A, Zeilman P, Fernandez H, Bajwa J, Mehanna R . DBS Programming: An Evolving Approach for Patients with Parkinson's Disease. Parkinsons Dis. 2017; 2017:8492619. PMC: 5632902. DOI: 10.1155/2017/8492619. View

2.
Gross R, Krack P, Rodriguez-Oroz M, Rezai A, Benabid A . Electrophysiological mapping for the implantation of deep brain stimulators for Parkinson's disease and tremor. Mov Disord. 2006; 21 Suppl 14:S259-83. DOI: 10.1002/mds.20960. View

3.
Steigerwald F, Muller L, Johannes S, Matthies C, Volkmann J . Directional deep brain stimulation of the subthalamic nucleus: A pilot study using a novel neurostimulation device. Mov Disord. 2016; 31(8):1240-3. PMC: 5089579. DOI: 10.1002/mds.26669. View

4.
Santaniello S, Gale J, Sarma S . Systems approaches to optimizing deep brain stimulation therapies in Parkinson's disease. Wiley Interdiscip Rev Syst Biol Med. 2018; 10(5):e1421. PMC: 6148418. DOI: 10.1002/wsbm.1421. View

5.
Dembek T, Reker P, Visser-Vandewalle V, Wirths J, Treuer H, Klehr M . Directional DBS increases side-effect thresholds-A prospective, double-blind trial. Mov Disord. 2017; 32(10):1380-1388. DOI: 10.1002/mds.27093. View